Search This Blog

Thursday, July 16, 2020

Johnson & Johnson EPS beats by $0.16, beats on revenue

Johnson & Johnson (NYSE:JNJ): Q2 Non-GAAP EPS of $1.67 beats by $0.16; GAAP EPS of $1.36 beats by $0.18.
Revenue of $18.34B (-10.8% Y/Y) beats by $610M.
Consumer Health revenue of $3.3B vs. consensus of $3.54B
Press Release

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)